6BOF
Crystal structure of KRAS A146T-GDP demonstrating open switch 1 conformation
6BOF の概要
| エントリーDOI | 10.2210/pdb6bof/pdb |
| 分子名称 | GTPase KRas, GUANOSINE-5'-DIPHOSPHATE (3 entities in total) |
| 機能のキーワード | hydrolase, small gtpase, signal transduction, gdp binding |
| 由来する生物種 | Homo sapiens (Human) |
| タンパク質・核酸の鎖数 | 2 |
| 化学式量合計 | 39227.58 |
| 構造登録者 | |
| 主引用文献 | Poulin, E.J.,Bera, A.K.,Lu, J.,Lin, Y.J.,Strasser, S.D.,Paulo, J.A.,Huang, T.Q.,Morales, C.,Yan, W.,Cook, J.,Nowak, J.A.,Brubaker, D.K.,Joughin, B.A.,Johnson, C.W.,DeStefanis, R.A.,Ghazi, P.C.,Gondi, S.,Wales, T.E.,Iacob, R.E.,Bogdanova, L.,Gierut, J.J.,Li, Y.,Engen, J.R.,Perez-Mancera, P.A.,Braun, B.S.,Gygi, S.P.,Lauffenburger, D.A.,Westover, K.D.,Haigis, K.M. Tissue-Specific Oncogenic Activity of KRASA146T. Cancer Discov, 9:738-755, 2019 Cited by PubMed Abstract: is the most frequently mutated oncogene. The incidence of specific alleles varies between cancers from different sites, but it is unclear whether allelic selection results from biological selection for specific mutant KRAS proteins. We used a cross-disciplinary approach to compare KRAS, a common mutant form, and KRAS, a mutant that occurs only in selected cancers. Biochemical and structural studies demonstrated that KRAS exhibits a marked extension of switch 1 away from the protein body and nucleotide binding site, which activates KRAS by promoting a high rate of intrinsic and guanine nucleotide exchange factor-induced nucleotide exchange. Using mice genetically engineered to express either allele, we found that KRAS and KRAS exhibit distinct tissue-specific effects on homeostasis that mirror mutational frequencies in human cancers. These tissue-specific phenotypes result from allele-specific signaling properties, demonstrating that context-dependent variations in signaling downstream of different KRAS mutants drive the mutational pattern seen in cancer. SIGNIFICANCE: Although epidemiologic and clinical studies have suggested allele-specific behaviors for , experimental evidence for allele-specific biological properties is limited. We combined structural biology, mass spectrometry, and mouse modeling to demonstrate that the selection for specific KRAS mutants in human cancers from different tissues is due to their distinct signaling properties... PubMed: 30952657DOI: 10.1158/2159-8290.CD-18-1220 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (1.401 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






